Details
| Stereochemistry | MIXED |
| Molecular Formula | C23H31NO2 |
| Molecular Weight | 353.4977 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(OC(C)=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
InChI
InChIKey=XBMIVRRWGCYBTQ-UHFFFAOYSA-N
InChI=1S/C23H31NO2/c1-6-22(26-19(3)25)23(17-18(2)24(4)5,20-13-9-7-10-14-20)21-15-11-8-12-16-21/h7-16,18,22H,6,17H2,1-5H3
Methadyl Acetate is a narcotic analgesic with a long onset and duration of action. Methadyl Acetate is primarily a mu-type opioid receptor agonist and the drug decreases a patient's opioid use by preventing opioid withdrawal. Levacetylmethadol, the enantiomer of Methadyl Acetate, was approved in 1993 by the U.S. Food and Drug Administration for use in the treatment of opioid dependence. In 2001, levacetylmethadol was removed from the U.S. market due to reports of life-threatening ventricular rhythm disorders.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DEA NO. |
9601
Created by
admin on Mon Mar 31 18:39:39 GMT 2025 , Edited by admin on Mon Mar 31 18:39:39 GMT 2025
|
||
|
NCI_THESAURUS |
C67413
Created by
admin on Mon Mar 31 18:39:39 GMT 2025 , Edited by admin on Mon Mar 31 18:39:39 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
654
Created by
admin on Mon Mar 31 18:39:39 GMT 2025 , Edited by admin on Mon Mar 31 18:39:39 GMT 2025
|
PRIMARY | |||
|
DB01433
Created by
admin on Mon Mar 31 18:39:39 GMT 2025 , Edited by admin on Mon Mar 31 18:39:39 GMT 2025
|
PRIMARY | |||
|
6814
Created by
admin on Mon Mar 31 18:39:39 GMT 2025 , Edited by admin on Mon Mar 31 18:39:39 GMT 2025
|
PRIMARY | RxNorm | ||
|
1729
Created by
admin on Mon Mar 31 18:39:39 GMT 2025 , Edited by admin on Mon Mar 31 18:39:39 GMT 2025
|
PRIMARY | |||
|
208-103-4
Created by
admin on Mon Mar 31 18:39:39 GMT 2025 , Edited by admin on Mon Mar 31 18:39:39 GMT 2025
|
PRIMARY | |||
|
C91045
Created by
admin on Mon Mar 31 18:39:39 GMT 2025 , Edited by admin on Mon Mar 31 18:39:39 GMT 2025
|
PRIMARY | |||
|
509-74-0
Created by
admin on Mon Mar 31 18:39:39 GMT 2025 , Edited by admin on Mon Mar 31 18:39:39 GMT 2025
|
PRIMARY | |||
|
Acetylmethadol
Created by
admin on Mon Mar 31 18:39:39 GMT 2025 , Edited by admin on Mon Mar 31 18:39:39 GMT 2025
|
PRIMARY | |||
|
D008692
Created by
admin on Mon Mar 31 18:39:39 GMT 2025 , Edited by admin on Mon Mar 31 18:39:39 GMT 2025
|
PRIMARY | |||
|
m7287
Created by
admin on Mon Mar 31 18:39:39 GMT 2025 , Edited by admin on Mon Mar 31 18:39:39 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID2023274
Created by
admin on Mon Mar 31 18:39:39 GMT 2025 , Edited by admin on Mon Mar 31 18:39:39 GMT 2025
|
PRIMARY | |||
|
CHEMBL170179
Created by
admin on Mon Mar 31 18:39:39 GMT 2025 , Edited by admin on Mon Mar 31 18:39:39 GMT 2025
|
PRIMARY | |||
|
SUB05232MIG
Created by
admin on Mon Mar 31 18:39:39 GMT 2025 , Edited by admin on Mon Mar 31 18:39:39 GMT 2025
|
PRIMARY | |||
|
L59OC40KWJ
Created by
admin on Mon Mar 31 18:39:39 GMT 2025 , Edited by admin on Mon Mar 31 18:39:39 GMT 2025
|
PRIMARY | |||
|
10517
Created by
admin on Mon Mar 31 18:39:39 GMT 2025 , Edited by admin on Mon Mar 31 18:39:39 GMT 2025
|
PRIMARY | |||
|
100000084601
Created by
admin on Mon Mar 31 18:39:39 GMT 2025 , Edited by admin on Mon Mar 31 18:39:39 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
METABOLITE (PARENT)
SALT/SOLVATE (PARENT)
